Opzelura Shortage Update for 2026

If you've had trouble filling your Opzelura (Ruxolitinib cream) prescription recently, you're probably wondering: is there an actual shortage? The answer isn't straightforward — and that's exactly what makes this so frustrating for patients.

In this article, we'll give you the latest update on Opzelura availability in 2026, explain why it's been hard to find, break down the current cost situation, and share practical steps you can take to get your medication.

Is Opzelura Still in Shortage?

As of early 2026, Opzelura is not listed in the FDA's official drug shortage database. This means there's no formal, manufacturer-reported supply disruption affecting the medication nationwide.

However, many patients continue to report difficulty finding Opzelura at their local pharmacies. This disconnect — between no official shortage and real-world availability problems — is common with specialty medications.

The issue isn't that Opzelura doesn't exist in the supply chain. It's that the medication doesn't make it to every pharmacy shelf. Because Opzelura is a high-cost specialty drug, it's primarily distributed through specialty pharmacy channels rather than standard retail pharmacies.

Why Is Opzelura Hard to Find?

There are several factors working together to make Opzelura difficult to find:

1. Specialty Distribution Model

Opzelura is classified as a specialty medication. This means it's distributed through a limited network of specialty pharmacies rather than being widely stocked at every CVS, Walgreens, or neighborhood pharmacy. If your doctor sends the prescription to a regular retail pharmacy, they may need to special-order it — or they may not be able to get it at all.

2. High Unit Cost

At approximately $1,900 to $2,200 per 60-gram tube without insurance, Opzelura is expensive. Many retail pharmacies are reluctant to stock medications at this price point because of the financial risk of unsold inventory. This means most pharmacies only order it when they have a specific prescription in hand.

3. Insurance Barriers

Most insurance plans require prior authorization and often step therapy before covering Opzelura. These administrative hurdles create delays that can make it seem like the medication is unavailable, when in reality the issue is insurance processing time.

4. Increasing Demand

As awareness of Opzelura grows — especially for vitiligo, where it's the first FDA-approved pharmacologic treatment — more patients are seeking prescriptions. This increased demand, combined with limited distribution points, can create localized availability gaps.

For a detailed breakdown of all the reasons, read why Opzelura is so hard to find in 2026.

How Much Does Opzelura Cost in 2026?

Here's a breakdown of current Opzelura pricing:

• Cash price (no insurance): Approximately $1,900 to $2,200 per 60-gram tube
• With commercial insurance: Varies widely; copays can range from $0 (with manufacturer coupon) to several hundred dollars depending on your plan
• Manufacturer copay program: Eligible commercially insured patients can pay as little as $0 per fill through the Incyte copay savings program
• Patient assistance (uninsured): IncyteCARES offers assistance for eligible uninsured or underinsured patients

No generic version of Opzelura is available as of 2026. For more ways to reduce your costs, see our guide on how to save money on Opzelura.

Are There New Treatment Options in 2026?

The treatment landscape for atopic dermatitis and vitiligo continues to evolve. While Opzelura remains the only topical JAK inhibitor on the market, other treatments are available:

• For atopic dermatitis: Eucrisa (Crisaborole), Protopic (Tacrolimus), Elidel (Pimecrolimus), and Dupixent (Dupilumab) remain available options
• For vitiligo: Opzelura is still the only FDA-approved pharmacologic treatment, though off-label topical options and phototherapy are alternatives

Read our full guide on alternatives to Opzelura for detailed information on each option.

How to Find Opzelura in Stock Right Now

Here are the most effective steps you can take today:

1. Search on Medfinder: Use Medfinder to find pharmacies near you that currently have Opzelura in stock
2. Contact specialty pharmacies: Ask your dermatologist's office which specialty pharmacies they work with for Opzelura prescriptions
3. Start prior authorization early: The sooner you begin the insurance approval process, the sooner you'll have your medication
4. Call IncyteCARES: Reach out to Incyte's patient support at 1-855-463-3463 for help finding a pharmacy and navigating insurance
5. Consider mail-order: Specialty mail-order pharmacies can deliver Opzelura directly to your home

For a complete walkthrough, see how to find Opzelura in stock near you.

Final Thoughts

While there's no official Opzelura shortage in 2026, the reality is that many patients are still having a hard time getting their prescriptions filled. The combination of specialty distribution, high cost, and insurance requirements creates real barriers — even when supply exists.

The key is to be proactive. Use tools like Medfinder, work with specialty pharmacies, and start the insurance process as early as possible. With the right approach, you can get the Opzelura you need without unnecessary delays.